Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
" it's that the former rights"
Dont they have to honor the "former rights"?
If not, what was the "former rights"?
*****(((( THE BIGGEST UNANSWERED QUESTIONS:...
WHY DID THE INSIDER HOLDINGS OF 72Million SHARES NOT MENTIONED IN DEF 14A?
ONLY MENTIONED SOME SHARES AS OF NOV 17 2017?.
THEY WANT TO DISCOURAGE THE RETAIL AND GET THE CHEAPIES BEFORE ANNOUNCING ANYTHING PRETTY $OON.
IMO.
FORM 10 PRETTY $OON
IMO.
INSIDERS OWN 14% 71MILLION SHARES NOT DISCLOSED IN DEF 14A
WHY?
They want to discourage the retail holders to buy the shares and drain them out before they announce the acquisition of Jamestown Hospital,10K,the new revenues from the Big south fork hospital and SPIN-OFF.
I hold even if it goes to 0.0001, why?.
I get compensated thru these shares + the dividend shares in SPIN-OFF.
INSIDERS OWN 14% 71MILLION SHARES - 8K
Unregistered Sales of Equity Securities.
On March 6, 2018, the Board of Directors (the “Board”) of Rennova Health, Inc. (the “Company”), based on the recommendation of the Compensation Committee of the Board, approved grants to employees and directors of an aggregate of 71,333,331 shares of common stock, including the following to the directors of the Company:
Seamus Lagan 26,666,667 shares
Dr. Kamran Ajami 3,333,333 shares
John Beach 3,333,333 shares
Gary L. Blum 3,333,333 shares
Christopher Diamantis 3,333,333 shares
Trevor Langley 3,333,333 shares
https://www.sec.gov/Archives/edgar/data/931059/000149315218003098/form8-k.htm
as of November 17, 2017 Security Ownership of Certain Beneficial Owners
WHY NOVEMBER 17,2017?
WHY NOT AS OF 03/07/2018?
The following table summarizes certain information regarding the beneficial ownership (as such term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) of our outstanding Common Stock as of November 17, 2017 by (i) each person known by us to be the beneficial owner of more than 5% of the outstanding Common Stock, (ii) each of our directors, (iii) each of our executive officers, and (iv) all executive officers and directors as a group. Except as indicated in the footnotes below, the stockholders listed below possess sole voting and investment power with respect to their shares. None of the following owns any Series F Preferred Stock.
Name of Beneficial Owner No. of Shares of Common Stock Owned Percentage of
Ownership(1)
Seamus Lagan 27,158 (2) *
Dr. Kamran Ajami 8,567 (3) *
John Beach - -
Gary L. Blum - -
Christopher E. Diamantis 100,843 (4) 1.76 %
Trevor Langley 6,666 –
Michael Pollack – (5) –
Epizon Ltd. 8,638 (6) *
All Directors and Executive Officers as a Group (6 persons) 143,234 (7)(8) 2.50 %(8)
Sabby Healthcare Master Fund, Ltd. (9) 563,403 9.99 %
Sabby Volatility Warrant Master Fund, Ltd. (9) 563,403 9.99 %
STOCK SURVIVE A RS - 3
10-q OF THIS QUARTER AND 2017 10-k SHOW REVENUES DRASTICALLY IMPROVED, THE STOCK WILL SKYROCKET,AT THAT MOMENT BOD MAY DROP THE IDEA OF RS.
stock survive a R/S? -2
BASED ON THE POSITIVE NEWS SUCH AS
1. JAMESTOWN HOSPITAL ACQUISITION.
2. AUDITED 10-K SHOWING THE IMPROVED REVENUES FROM BIG SOUTH FORK HOSPITAL.
3. REDUCED LIABILITIES.
4. SPIN-OFF
THE PRICE COULD GO BACK TO WHERE IT WAS FEW MONTHS AGO IMO.
IF IT GOES BACK TO 25 TO 50 CENTS RANGE, ITS GOOD TO RS AT THAT TIME.
stock survive a R/S?
IT DEPENDS ON
1. JAMESTOWN HOSPITAL ACQUISITION.
2. AUDITED 10-K SHOWING THE IMPROVED REVENUES FROM BIG SOUTH FORK HOSPITAL.
3. REDUCED LIABILITIES.
4. SPIN-OFF
DEF 14 SHOWING INSIDER HOLDINGS AS OF NOV 2017, NOT AS OF 3/08/2018.
72MILLION SHARES OR 14% IS OWNED BY INSIDERS.
From IR
Company is doing auditing of its 10-K which is due this month.They need it to work the spin-off.
James town hospital acquisition will be huge and might increase the share price raise.
Good thing is we will see audited financial results, that might change the equity position.
AND REVENUES OF $46 Million
+
JAMES TOWN HOSPITAL HISTORICAL $90MM ANNUAL REVENUES
CUTTING EDGE TECHNOLOGY
3.3 Deep learning for temporal patient data
Due to the longitudinal nature of EHR data, many applications employ deep network architectures that
are capable of extraction of temporal patterns from it, such as recurrent neural networks (RNNs), Long
Short-Term Memory networks (LSTMs), etc. [91]. These networks are used for mapping patient
trajectories with temporal predictions of clinical outcomes, outperforming conventional machine
learning methods that typically require a single “snapshot” in time, and are not as robust for longitudinal
modeling [99-101]. Several methods have been proposed to deal with the complex nature of
longitudinal EHR data, specifically because of temporality from clinical records. To account for possible
interventions and predict optimal treatment strategy, deep learning approaches were shown to be
efficient when combined with reinforcement learning. For example, Kale et al. demonstrated how this
type of deep model can be used for discovery and analysis of causal phenotypes from clinical time
series data [102]. Deep neural networks trained on EHR data with temporally dependent constraints
and outputs have also been proposed to predict 3-12-month mortality of patients receiving improved
palliative care [46]. Additional deep reinforcement learning models have been used to learn an optimal
heparin dosing policy from sample dosing trials. Their associated outcomes having been predicted from
the publicly available MIMIC II intensive care unit database [10
Looking forward, we also envision the incorporation of data from mobile devices and wearable sensors
for measuring phenotypic markers and stratification of patients by these phenotypes. This type of
continuously collected data allows researchers access to large-scale deep phenotyping of the human
population, and to better assess patients’ prognosis by analyzing their real-time data. Rajpurkar et al.
developed a 34-layer convolutional neural network which exceeded the performance of board certified
cardiologists in detecting a wide range of heart arrhythmias from electrocardiograms recorded with a
single-lead wearable monitor [104]. Apple’s ResearchKit open-source framework enables access to
enrolled patients’ heart rate, accelerometer, and other mobile sensor data [105]. For example, the
approach utilizing deep convolutional neural networks for feature extraction from accelerometry and
gyroscope iPhone data has recently won the Parkinson’s Disease Digital Biomarker (PDDM) DREAM
challenge, an open crowd-sourced research project designed to benchmark the use of remote sensors
to diagnose and track Parkinson’s disease [106]. Similar studies with recurrent neural networks have
22
also shown to be successful in classification of patients with bipolar disorder using NLP and
accelerometer data collected from a patient’s mobile device [107]. Although data from wearable
sensors isn’t yet considered to be a part of a patient’s electronic health record, this data has shown to
be robust and usable with deep learning methods and will certainly contribute to the modernization of
patient stratification
Meeting the stockholders' equity requirement of NASDAQ.
So each share of AMSG would be atleast $2?.
Each RNVA will have one RNVA + one AMSG?
curing the net equity deficiency and meeting the stockholders' equity requirement of NASDAQ.
So each share of AMSG would be atleast $2?.
Each RNVA will have one RNVA + one AMSG?
That would give a market capital of more than a $Billion.
Do you know what it means?
IRC 1504
Fresh Start
61 months waiting
MACHINE LEARNING/AI COMPANY/AMSG
https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=528643898
Advanced Molecular Services Group, Inc. develops systems, proprietary clinical data, patented molecular testing, and machine learning/artificial intelligence. The company focuses on mental and behavioral health, oncology, urology, and cardiovascular disease. It provides advanced machine learning in precision medicine to patients, physicians, and care teams in the United States. The company is based in West Palm Beach, Florida. Advanced Molecular Services Group, Inc. operates as a subsidiary of Rennova Health, Inc.
Shorts will be toasted as soon as the spin off announcement is made.
$00n
Where is LTs 10-K?.
THIS IS A GOLDMINE
"Precision medicine is exploding in part because of advances in diagnostic technologies and machine learning. Rennova has these key components to be a leader in this space," says Dr. Jenkins. "Every patient, physician and health organization needs immediate access to these life-changing tools, and we are going to deliver them."
http://www.marketwired.com/press-release/rennova-health-announces-formation-advanced-molecular-services-group-may-spin-off-group-nasdaq-rnva-2214079.htm
REVENUES 2018
We believe that we can achieve the following revenues for 2018
o $600K per month for toxicology and clinical diagnostics
o $400K per month for software and RCM related revenue
o $1M per month from our hospital in TN
Subject to acquisition
o $800K per month from Dr’s practices
o $1M per month from acquisition of additional hospital
Potential revenue of $3.8M per month or $45.6M per annum
Penny stock to atleast $2 stock pretty $oon
AJMHO.
ANTI DILUTION - FULL RATCHET
https://www.sec.gov/Archives/edgar/data/931059/000149315217014724/form8-k.htm
Conversion. Each share of Preferred Stock is convertible into shares of the Company’s common stock at any time at the option of the holder at a conversion price equal to the lesser of (i) $1.00, subject to adjustment, and (ii) 85% of the lesser of the volume weighted average market price of the common stock on the day prior to conversion or on the day of conversion. The conversion price is subject to “full ratchet” and other customary anti-dilution protections as more fully described in the Certificate of Designation of the Preferred Stock. Holders of the Preferred Stock are prohibited from converting Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 4.99% (or, upon election of the holder, 9.99%) of the total number of shares of common stock then issued and outstanding. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days after notice to the Company.
https://www.investopedia.com/terms/f/fullratchet.asp
What is the deal with increasing the AS?
AS were 500 mil, issued are at 490mil.No shares available any more.
When will that be determined?
If shareholders approve as per Def 14, they might authorize to issue,down the line when they need to raise capital or convert debt.Or never need to issue due to drastic improvement in revenues and positive equity.
Q1 Q2 Q3 EXPECTATIONS AND STOCK PRICE
1. HOSPITAL 2 ACQUISITIONS ONGOING NOW AS PER CEO INTERVIEW, SO IT IS SAFE TO ESTIMATE THAT IT GETS CLOSED BY APRIL1 OR IN Q2.
2. HOSPITAL 1 REVENUE IS ALREADY STARTED TO FLOW.
3. POSITIVE EQUITY BY SPIN-OFF AND INCLUDING THAT IN THE BALANCE SHEET.
4. TOXIC LENDERS SHORTED IT TO 0.0005, THEY WILL BUMP IT UP.
5. WITH POSITIVE EQUITY AND $46MILLION ANNUAL REVENUES, IMAGINE THE SHARE PRICE.
I WILL STAY.AJMHO.
My point is even pennys as direct cash distribution, would be humongous to current shareholders, it reflects on the stock price too.
They have $17mm negative equity, you add it with around 20-30mm, you would end up with 3 to 13mm positive equity.
Just hypothetically speaking.
Anyways, its good to know that all these things are about to happen this quarter and we are almost there at the end of the quarter.
RNVA will shoot up $oon
JMHO.
+VE EQUITY - CURING EQUITY DEFICIENCY
PRETTY $oon
As of June 30, 2017, our balance sheet had negative stockholders' equity of approximately $17 million, compared with negative $65 million as of March 31, 2017. This improvement is due in large part to changes in accounting practices for derivative liabilities, which are fully explained in our June 30, 2017 Form 10-Q filing with the Securities and Exchange Commission. Additionally, there were significant conversions of debt by existing debenture holders.
As we have previously informed you, as part of our plan to regain compliance with NASDAQ's stockholders' equity continued-listing requirement, in the near future Rennova intends to spin-off to its stockholders our genetic testing division, Advanced Molecular Services Group, Inc. (AMSG), and our IT and Software division, Health Technology Solutions, Inc. (HTS). To date we have invested more than $20 million in these businesses. Rennova's Board has decided to spin-off these businesses directly to our stockholders in anticipation that the market will better appreciate the focused business plan and management of each division separately, while allowing Rennova to focus on its core competencies. In addition, we expect that we will be able to recognize our investment in these businesses as equity on our balance sheet, further reducing and largely curing the net equity deficiency and meeting the stockholders' equity requirement of NASDAQ.
TAX FREE DISTRIBUTION TO SHAREHOLDERS
COULD IT BE FEW CENTS/SHARE?
Nice post.The company can get rid of loss generating assets, good decision that they are moving towards buying distressed hospitals and regenerate revenues.The debt was converted to stock and there is some additional debt due in Sept 2019.Very interesting to watch the turn around of the company and its business model.
The losses were there on the books and the stock price reflected that.All you said looks like truth,but you are missing the big picture of $46MM revenues projected for 2018.It is happening now as mentioned in 8-K.
$oon.
One sane post.This will take another quarter atleast.We should see the 10-K 2017 and 10Q of 1st qtr of 2018 how the Hospital acquired in Sept 2017 is doing and impacting the revenues in a positive way.
Which penny stock company with projected $46MM revenue is there?
DEBT IS RESTRUCTURED IF YOU KNOW WHAT AM I TALKING ABOUT, DUE IN SEPT 2019.
CEO SAID THIS AND FILED IN AN 8-K
Lagan: I think you covered quite a lot of it, you hit the key points. Obviously, we have secured a lot of outside capital in 2016 and 2017. I think we are well positioned, as I said, to see our revenues grow to where our levels of debt are pretty insignificant compared to revenue as this year goes on. Obviously, that was not the case for the past two years and I believe it hurt us in the marketplace. I think that once we get the next couple of quarters over and people are more assured that that growth is actually taking place, I think you’ll see a different valuation on our company before the year is over.
https://www.sec.gov/Archives/edgar/data/931059/000149315218002960/ex99-2.htm
IF THEY WANT TO DO RS, THE CURRENT PRICE SHOULD GO UPTO AROUND 20CENTS.
AND THEY DID THAT ON 3/06/2018....NOT LAST YEAR
THEY ALL GOT IT AS STOCK BASED COMPENSATION AS DEFINED IN ASC rules.
DEBT IS DUE IN SEPT 2019
DEBT IS INSIGNIFICANT vs REVENUE AS PER CEO IN 8-K
IT WILL REACH $ + PRETTY SOON
AJMHO
CEO HOLDING 26Million SHARES
SEPT 2017 HOSPITAL REVEUNE
Net revenues $ 619,478
Just in the beginning when they acquired it.
INSIDERS HOLD 72 Million SHARES
Here we go hope everyone loaded! --- Including CEO & BOD
CEO COMMENTS INSIGNIFICANT DEBT vs REVENUE
Lagan: I think you covered quite a lot of it, you hit the key points. Obviously, we have secured a lot of outside capital in 2016 and 2017. I think we are well positioned, as I said, to see our revenues grow to where our levels of debt are pretty insignificant compared to revenue as this year goes on. Obviously, that was not the case for the past two years and I believe it hurt us in the marketplace. I think that once we get the next couple of quarters over and people are more assured that that growth is actually taking place, I think you’ll see a different valuation on our company before the year is over.
https://www.sec.gov/Archives/edgar/data/931059/000149315218002960/ex99-2.htm
$oon IMO
1st TIME INSIDERS LOADED WITH COMMON STOCK
72Million owned by employees ,BOD and CEO.
That tells the entire story where this is heading.
Just wait for 10-K.